Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...
KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present ...
Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
The FDA granted orphan designation to Sanofi (SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on ...
1d
GlobalData on MSNSanofi and Teva report new outcomes from Phase IIb trial of duvakitugSanofi and Teva Pharmaceuticals have reported new outcomes from the randomised Phase IIb RELIEVE UCCD trial of human ...
Sanofi's investment raises the value of Orano Med to €1.9 billion and gives it a 16% stake in the company, which focuses on the development of radiotherapies based on lead-212, an isotope that ...
Lead the technical development, testing and implementation of advanced Large Language Model (LLM) based projects and related technologies to deliver end-to-end data science and AI products using ...
Lead the technical development, testing and implementation of advanced Large Language Model (LLM) based projects and related technologies to deliver end-to-end data science and AI products using ...
This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...
Investigates found test results from the Indian Forest neighborhood in Montgomery County show lead in tap water exceeds EPA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results